Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-7,520 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
N/A
-3,660 Reduced 32.74%
7,520 $40,000
Q1 2021

May 17, 2021

BUY
N/A
8,154 Added 269.46%
11,180 $54,000
Q4 2020

Feb 16, 2021

SELL
N/A
-4,100 Reduced 57.54%
3,026 $13,000
Q3 2020

Nov 16, 2020

BUY
N/A
6,299 Added 761.67%
7,126 $29,000
Q2 2020

Aug 13, 2020

SELL
N/A
-3,877 Reduced 82.42%
827 $2,000
Q1 2020

May 15, 2020

BUY
N/A
4,704 New
4,704 $14,000
Q4 2019

Feb 07, 2020

SELL
N/A
-1,007 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
N/A
1,007 New
1,007 $5,000
Q2 2019

Aug 13, 2019

SELL
N/A
-2,093 Closed
0 $0
Q1 2019

May 14, 2019

BUY
N/A
1,337 Added 176.85%
2,093 $15,000
Q4 2018

Feb 14, 2019

SELL
N/A
-7,343 Reduced 90.67%
756 $6,000
Q3 2018

Nov 13, 2018

BUY
N/A
8,099 New
8,099 $162,000
Q2 2018

Aug 15, 2018

SELL
N/A
-2,241 Closed
0 $0
Q1 2018

May 15, 2018

BUY
N/A
2,241 New
2,241 $54,000
Q4 2017

Feb 09, 2018

SELL
N/A
-1,483 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
N/A
1,483
1,483 $31,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.